Oral News and Research

RSS

New male contraceptive pill could soon be available

A new male contraceptive could be on the horizon after scientists identified a novel way to block the transport of sperm during ejaculation.

4 Dec 2013

Obese patients receive needless respiratory treatment

Research from the USA shows that a substantial proportion of obese patients are prescribed bronchodilators, even after spirometry indicates a lack of lung obstruction.

3 Dec 2013

Investigational c-Met inhibitor shows early promise in NSCLC

A first-in-class drug that inhibits c-Met, a receptor tyrosine kinase, has demonstrated good tolerability when combined with erlotinib in the treatment of Japanese patients with advanced/metastatic non-small-cell lung cancer.

3 Dec 2013

First Edition: December 3, 2013

Today's headlines include coverage of the mixed reviews regarding healthcare.gov's "relaunch" as well as the White House strategy to move past the website's difficulties.

3 Dec 2013

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.

3 Dec 2013

New finding links obesity and high-fat, high-sugar diets with changes in inflammatory status

Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats.

3 Dec 2013

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today the creation of TocopheRx, a Boston-based spin-off company resulting from the Entrepreneur Partnership Program launched by Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, in April 2012.

3 Dec 2013

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.

2 Dec 2013

Poor oral hygiene, excess sugar consumption linked to heart disease

The association between poor oral health and increased risk of cardiovascular disease should make the reduction of sugars such as those contained in junk food, particularly fizzy drinks, an important health policy target, say experts writing in the Journal of the Royal Society of Medicine.

28 Nov 2013

Pediatric dermatologists offer tips for treating skin ailments

As parents across the Chicago area prepare to take that perfect holiday photo to send to family and friends, they may want to consider more than just getting their kids to smile and look at the camera.

28 Nov 2013

Leti highlights new imaging technology at IEEE Nuclear Science Symposium & Medical Imaging Conference

Researchers from CEA-Leti’s Detector Laboratory presented four oral papers and one invited paper at the recent IEEE Nuclear Science Symposium & Medical Imaging Conference & Workshop on Room-Temperature Semiconductor X-Ray and Gamma-Ray Detectors in Seoul, Korea.

28 Nov 2013

Loyola dermatologist offers skin care tips for holidays

The holidays often bring freezing temperatures, limited sleep, sugary treats and cocktails. This combination can spell trouble for your skin, according to a dermatologist at Loyola University Health System.

28 Nov 2013

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far.

27 Nov 2013

Supreme Court to hear arguments on health law's contraceptive coverage mandate

The justices accepted a pair of cases that raise questions not just about religious freedom and equality for female employees, but whether the religious beliefs of the owners of secular corporations allows them to not comply with a law.

27 Nov 2013

Nonabsorbable antibiotics effective in eradicating CRE colonization

Orally administered, nonabsorbable antibiotics were effective in eradicating carbapenem-resistant Enterobacteriaceae (CRE) colonization, according to a new study published in the December issue of the American Journal of Infection Control, a publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

27 Nov 2013

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL® (posaconazole) 100 mg delayed-release tablets.

27 Nov 2013

USF is among top 10 organizations worldwide with Fellows named this year

Six faculty members at the University of South Florida in Tampa have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.

26 Nov 2013

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their healthcare provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels.

26 Nov 2013

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

The application for European marketing authorisation of faldaprevir, a potent second generation oral protease inhibitor, has been fully validated and granted accelerated assessment by the European Medicines Agency (EMA).

26 Nov 2013

Study defines HRV reference values for children

Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.

26 Nov 2013

Oral News and Research

New male contraceptive pill could soon be available

Obese patients receive needless respiratory treatment

Investigational c-Met inhibitor shows early promise in NSCLC

First Edition: December 3, 2013

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

New finding links obesity and high-fat, high-sugar diets with changes in inflammatory status

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Poor oral hygiene, excess sugar consumption linked to heart disease

Pediatric dermatologists offer tips for treating skin ailments

Leti highlights new imaging technology at IEEE Nuclear Science Symposium & Medical Imaging Conference

Loyola dermatologist offers skin care tips for holidays

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Supreme Court to hear arguments on health law's contraceptive coverage mandate

Nonabsorbable antibiotics effective in eradicating CRE colonization

Merck announces approval of NOXAFIL delayed-release tablets by FDA

USF is among top 10 organizations worldwide with Fellows named this year

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

Study defines HRV reference values for children

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News